North American Scientific to divest Nomos unit

By staff writers

August 3, 2007 -- Chatsworth, CA-based radiation therapy developer North American Scientific (NAS) will divest its Nomos radiation oncology business.

The company also plans to renew marketing and development of its brachytherapy products for the treatment of cancer, which include Prospera brachytherapy seeds and SurTrak needles, and strands used primarily in the treatment of prostate cancer.

In addition, NAS will continue with plans to commercialize its ClearPath multichannel catheter breast brachytherapy devices in 2007.

By staff writers
August 3, 2007

Related Reading

NAS calls in new BatCam, July 23, 2007

NAS receives Premier renewal, July 2, 2007

NAS taps Rush as president, CEO, March 23, 2007

NAS revenues edge up, but loss widens in Q1, March 15, 2007

NAS trims year-end losses, January 12, 2007

Copyright © 2007


To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking